Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of MK-1942 Administered to Alzheimer's Disease Patients Receiving Donepezil Treatment.
Conditions
Interventions
MK-1942
Donepezil
+1 more
Locations
4
United States
Woodland Research Northwest, LLC ( Site 0004)
Rogers, Arkansas, United States
Velocity Clinical Research, Hallandale Beach ( Site 0002)
Hallandale, Florida, United States
iResearch Atlanta ( Site 0005)
Decatur, Georgia, United States
ICON ( Site 0003)
Salt Lake City, Utah, United States
Start Date
February 16, 2021
Primary Completion Date
May 18, 2022
Completion Date
May 18, 2022
Last Updated
August 15, 2024
NCT07033494
NCT06159673
NCT07457138
NCT07422857
NCT07214727
NCT06584357
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions